VINEETLAB · Basic Materials · Chemicals
| Share price | ₹37.43 |
| Market cap | ₹72 Cr |
| P/B ratio | 2.5 |
| ROCE | -84.1% |
| Book value | ₹15.25 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2025 | ₹75 Cr | ₹-20 Cr | -25.0% |
| 2024 | ₹151 Cr | ₹1 Cr | 3.1% |
| 2023 | ₹212 Cr | ₹1 Cr | 2.7% |
| 2022 | ₹191 Cr | ₹7 Cr | 5.8% |
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chlorid